David A Kalmbach1, Vivek Pillai2, J Todd Arnedt1, Jason R Anderson2, Christopher L Drake3. 1. Sleep and Circadian Research Laboratory, Departments of Psychiatry and Neurology, University of Michigan Medical School, Ann Arbor, MI 48109, USA. 2. Sleep Disorders and Research Center, Henry Ford Hospital, Detroit, MI 48202, USA. 3. Sleep Disorders and Research Center, Henry Ford Hospital, Detroit, MI 48202, USA. Electronic address: cdrake1@hfhs.org.
Abstract
OBJECTIVES: To test for sensitization of the sleep system in response to insomnia development and major life stress. In addition, to evaluate the impact on depression and anxiety associated with sleep system sensitization. METHODS: A longitudinal study with three annual assessments. The community-based sample included 262 adults with no history of insomnia or depression who developed insomnia one year after baseline (67.6% female; 44.0 ± 13.4 yr). Measures included the Ford Insomnia Response to Stress Test to assess sleep reactivity, Quick Inventory of Depressive Symptomatology, and Beck Anxiety Inventory. Insomnia classification was based on DSM-IV criteria. Sleep system sensitization was operationally defined as significant increases in sleep reactivity. RESULTS: Sensitization of the sleep system was observed from baseline to insomnia onset at 1-yr follow-up among insomniacs with low premorbid vulnerability (p < 0.001), resulting in 68.3% of these individuals re-classified as highly sleep reactive. Major life stress was associated with greater sleep system sensitization (p = 0.02). Results showed that sleep reactivity at 2-yr follow-up remained elevated among those with low premorbid vulnerability, even after insomnia remission (p < 0.01). Finally, analyses revealed that increases in sleep reactivity predicted greater depression (p < 0.001) and anxiety (p < 0.001) at insomnia onset. The impact of sensitization on depression was stable at 2-yr follow-up (p = 0.01). CONCLUSIONS: Evidence supports sensitization of the sleep system as a consequence of insomnia development and major life stress among individuals with low premorbid sleep reactivity. Sleep system sensitization may serve as a mechanism by which insomnia is perpetuated. Harmful effects of the sensitization process may increase risk for insomnia-related depression and anxiety.
OBJECTIVES: To test for sensitization of the sleep system in response to insomnia development and major life stress. In addition, to evaluate the impact on depression and anxiety associated with sleep system sensitization. METHODS: A longitudinal study with three annual assessments. The community-based sample included 262 adults with no history of insomnia or depression who developed insomnia one year after baseline (67.6% female; 44.0 ± 13.4 yr). Measures included the Ford Insomnia Response to Stress Test to assess sleep reactivity, Quick Inventory of Depressive Symptomatology, and Beck Anxiety Inventory. Insomnia classification was based on DSM-IV criteria. Sleep system sensitization was operationally defined as significant increases in sleep reactivity. RESULTS: Sensitization of the sleep system was observed from baseline to insomnia onset at 1-yr follow-up among insomniacs with low premorbid vulnerability (p < 0.001), resulting in 68.3% of these individuals re-classified as highly sleep reactive. Major life stress was associated with greater sleep system sensitization (p = 0.02). Results showed that sleep reactivity at 2-yr follow-up remained elevated among those with low premorbid vulnerability, even after insomnia remission (p < 0.01). Finally, analyses revealed that increases in sleep reactivity predicted greater depression (p < 0.001) and anxiety (p < 0.001) at insomnia onset. The impact of sensitization on depression was stable at 2-yr follow-up (p = 0.01). CONCLUSIONS: Evidence supports sensitization of the sleep system as a consequence of insomnia development and major life stress among individuals with low premorbid sleep reactivity. Sleep system sensitization may serve as a mechanism by which insomnia is perpetuated. Harmful effects of the sensitization process may increase risk for insomnia-related depression and anxiety.
Authors: Eric A Nofzinger; Daniel J Buysse; Anne Germain; Julie C Price; Jean M Miewald; David J Kupfer Journal: Am J Psychiatry Date: 2004-11 Impact factor: 18.112
Authors: Ravi Singareddy; Alexandros N Vgontzas; Julio Fernandez-Mendoza; Duanping Liao; Susan Calhoun; Michele L Shaffer; Edward O Bixler Journal: Sleep Med Date: 2012-03-17 Impact factor: 3.492
Authors: Philip Cheng; David A Kalmbach; Hsing-Fang Hsieh; Andrea Cuamatzi Castelan; Chaewon Sagong; Christopher L Drake Journal: Psychol Med Date: 2022-03-08 Impact factor: 10.592
Authors: Thomas C Neylan; Ronald C Kessler; Kerry J Ressler; Gari Clifford; Francesca L Beaudoin; Xinming An; Jennifer S Stevens; Donglin Zeng; Sarah D Linnstaedt; Laura T Germine; Sophia Sheikh; Alan B Storrow; Brittany E Punches; Kamran Mohiuddin; Nina T Gentile; Meghan E McGrath; Sanne J H van Rooij; John P Haran; David A Peak; Robert M Domeier; Claire Pearson; Leon D Sanchez; Niels K Rathlev; William F Peacock; Steven E Bruce; Jutta Joormann; Deanna M Barch; Diego A Pizzagalli; John F Sheridan; Steven E Harte; James M Elliott; Irving Hwang; Maria V Petukhova; Nancy A Sampson; Karestan C Koenen; Samuel A McLean Journal: Sleep Date: 2021-03-12 Impact factor: 5.849
Authors: Anthony N Reffi; Christopher L Drake; David A Kalmbach; Tanja Jovanovic; Seth D Norrholm; Thomas Roth; Melynda D Casement; Philip Cheng Journal: J Sleep Res Date: 2022-08-29 Impact factor: 5.296
Authors: David A Kalmbach; Andrea S Cuamatzi-Castelan; Christine V Tonnu; Kieulinh Michelle Tran; Jason R Anderson; Thomas Roth; Christopher L Drake Journal: Nat Sci Sleep Date: 2018-07-17